#WorldDenseBreastDay will be held on September 27, 2023. Plans for the 24-hour Social Media Education Marathon follow news of the FDA’s new “dense breast” reporting requirement going into effect September 2024. Image courtesy of DenseBreast-info.org
September 12, 2023 — DenseBreast-info.org (DBI), a leading website on the topic of dense breasts, has announced that the second annual #WorldDenseBreastDay will be held on September 27, 2023. Plans for the 24-hour Social Media Education Marathon follow news of the FDA’s new “dense breast” reporting requirement going into effect September 2024. Other countries are following suit, and the European Society of Breast Imaging is now recommending that European women also be informed about their breast density.
The purpose of this worldwide one-day education marathon, according to its sponsor is to raise awareness about the screening and risk implications of dense breasts and share medically-sourced educational resources.
Building on the success of DBI’s 2022 inaugural event, #WorldDenseBreastDay will reach tens of thousands of patients, health providers and health organizations across the globe, noted the September 12 statement. The 2022 event engaged participants in 37 countries with over 8.6 million posts read. This year, in 2023, over 100 social media posts, including videos and dynamic visuals, in both English and Spanish, will kick-off #WorldDenseBreastDay beginning at midnight U.S.A./Eastern and running for 24 hours. Posts will include links to educational tools on the DenseBreast-info.org website addressing what breast density is, why it matters, and screening options for women with dense breasts. Medical providers, health organizations, researchers and the general public are encouraged to participate.
“The FDA Final Rule requires women be told if their breasts are dense or not dense and the European Society of Breast Imaging now recommends that European women be informed of their individual breast density. It is crucial to get ahead of what the educational needs will be,” said JoAnn Pushkin, Executive Director, DBI. She added, “DBI is the most comprehensive resource on the topic and this event has expanded globally to meet the growing need in the U.S.A. and beyond for medically-sourced information on the topic.”
“Forty percent of women of mammography age have dense breasts and mammograms miss about 40% of cancers in dense breasts,” said Wendie Berg, MD, PhD, FACR, Professor, Department of Radiology, University of Pittsburgh School of Medicine, and DBI Chief Scientific Advisor. “Many women with dense breasts would benefit from additional screening after their mammogram. The type of additional screening will depend on specific breast density and other risk factors as well as patient factors such as claustrophobia. Educational events like #WorldDenseBreastDay are essential to provide women and their health providers with the information needed to decide on optimal screening,” she added.
Growing from 40,000 visits in 2016, DenseBreast-info.org projects 750,000+ visits in 2023. DBI features provider resources and patient educational tools. DenseBreast-info, Inc., is a 501(c)(3) non-profit supported by unrestricted educational grants and donations from: GE HealthCare, Bayer Healthcare, Bayer AG, Myriad Genetics, Hologic, Delphinus Medical Technologies, Volpara Health, Beekley Medical, iCAD, CMR Naviscan, Bracco Diagnostics, and Vaso Healthcare.
Find more information at: www.DenseBreast-info.org
Related content:
VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule
One on One … with Wendie Berg, MD, PhD, FACR, FSBI
Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer
Creating Patient Equity: A Breast Density Legislative Update
February 06, 2026 
